- Assessed and managed a portfolio of inventions and potential commercial applications.- Performed market analysis, competitive studies, prior art searches, and patent landscape analysis.- Identified potential business partners and target markets.- Negotiated licenses and agreements and oversaw internal diligence prior to signing.- Coordinated activities across inventors, law firms, business partners, and tracked information in databases to include accurate, up-to-date information.

- Led, managed, and monitored collaborative scientific and business development projects.- Engaged with Key Opinion Leaders and stakeholders to understand market dynamics.- Conducted in-depth technical research, data compilation, analysis, and synthesis of literature, clinical trial data, market research, and competitive intelligence to drive decisions.- Identified and evaluated drug targets and created a database of potential drug targets.- Stayed abreast of emerging technologies and market trends via conferences and articles. - Performed scientific due diligence and assessed potential assets for in-licensing.- Identified potential partners for out-licensing and created a database for future use.- Created corporate documents, like databases, PowerPoints, white papers, and summaries.

- Led studies with external labs characterizing the pharmacology of our compound. - Performed data analysis and prepared reports to summarize mechanism studies.

- Assessed oligonucleotide-loaded extracellular vesicles (EVs) as a therapeutic for reducing cognitive decline in age-related dementia, chemo brain, and diabetic dementia.- Evaluated the effect of EVs on neuroinflammatory markers using biochemical, molecular, and histological assays, in vivo, in vitro, and ex vivo.

- Conducted competitive intelligence and market research studies on ophthalmological stem cell technologies used in Age-Related Macular Degeneration (AMD).- Engaged with Key Opinion Leaders (KOLs) within the ophthalmology field.

- Assessed Mesenchymal Stem Cell-derived Extracellular Vesicles (MSC-EVs) as a therapeutic in a monkey model of cortical injury, using behavioral, biochemical, and histological techniques.- Evaluated glial function and neuroinflammation in brain, serum, and CSF samples.- Prepared and published multiple manuscript publications and oral presentations.- Co-authored grant applications, including R01s, R21s, and an individual NRSA.

- Designed and executed in vitro experiments to assess lead compounds used to inhibit Neutrophil Extracellular Traps (NET) formation in support of Sickle Cell Disease projects.- Isolated neutrophils from whole human blood using a magnetic bead-based protocol.- Performed microfluidic experiments to observe NET roles in vasculature.

- Assessed lead compounds for reducing inflammation in Inflammatory Bowel Disease.- Designed and optimized protocols for future in vitro inflammation assays.

- Assisted with electrophysiology experiments to observe the role of copper dysfunction on circadian rhythms.

- Tested beta-blockers as an off-label therapeutic for anxiety in a rat fear-conditioned paradigm. - Behaviorally assessed anxiety in rats and analyzed behavioral data using AnyMaze and GraphPad Prism.

- Collaboratively created a quantitative model to predict alternans, electrical disturbances in the heart that preclude sudden Cardiac Arrest, using mathematical and statistical techniques.